Purification Of Recombinantly Produced Polypeptides

Patent No. EP2997036 (titled "Purification Of Recombinantly Produced Polypeptides") was filed by Medimmune on May 13, 2014. The application was issued on Mar 3, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GLAXOSMITHKLINEDec 3, 2021BELL
OETKEDec 3, 2021WALLINGER RICKER SCHLOTTER TOSTMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2997036

MEDIMMUNE
Application Number
EP14797310A
Filing Date
May 13, 2014
Status
Granted And Under Opposition
Jan 29, 2021
Publication Date
Mar 3, 2021